Addressing heterogeneity requires a multifaceted approach:
Combination Therapies: Using multiple drugs that target different pathways can help overcome resistance and improve treatment outcomes. Adaptive Therapy: Modifying treatment plans based on the tumor’s response can help manage resistance and prolong the efficacy of therapies. Biomarker Identification: Identifying biomarkers that indicate how a patient will respond to a particular treatment can guide therapy decisions.
